Character Group PLC
24 November 2003
The Character Group PLC ('Character Group' or 'the Company')
Significant shareholder notification
Pursuant to the announcement made by the Company on 12 November 2001, the
Company was today informed by Valtidone SpA ('Valtidone'), that it has disposed
of 4,000,000 ordinary shares of 5p each in the Company ('Ordinary Shares'). The
Company was also informed that the shares have been sold to four professional
investors.
Following the disposal referred to above, Valtidone no longer has an interest in
any Ordinary Shares. However, Valtidone retains an interest in £3,000,000
nominal of the convertible loan note issued by the Company on 16 July 2001
which, if fully converted, would result in the issue to it of a further
7,500,000 new Ordinary Shares.
24 November 2003
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.